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LETTERS TO THE EDITOR
EUS-guided ethanol ablation therapy 
for gastric stromal tumors
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Dear Editor, 
EUS-guided fine-needle ethanol injection (FNI) therapy of 
some types of cystic and solid tumors has been document-
ed. However, reported cases to date of gastrointestinal-stro-
mal tumors (GIST) treated with this technique are scarce. 
Ethanol ablation is an alternative treatment with a low rate 
of adverse events in selected cases (1-3). 
CASE REPORT
Two 82-year-old women with an associated cardiovascular 
co-morbidity and a history of upper gastrointestinal bleed-
ing were referred for endoscopic therapy of subepithelial 
lesions. These were located in the gastric cavity, measuring 
14 and 29-mm, and were suspected mesenchymal tumors. 
The EUS-guided fine needle (22G; Sharkcore, Covidien and 
Acquire, BostonSc) confirmed the diagnosis of GIST in both 
cases. Due to the age, comorbidity and clinical signs of 
digestive bleeding, EUS-FNI with an intratumoral 95% eth-
anol injection was performed. In the first case, 4 ml were 
injected with a standard 22G-needle (Echotip 3-22-Cook), 
and 2 ml with an ECHO-20-CPN needle with a spray effect 
on the tip were used in the second case. The treatment was 
well tolerated in both patients and there were no technical 
incidents or immediate adverse events, except for a mild 
increase of transaminases in the first case, without any clin-
ical repercussions. Endoscopic control was scheduled at 12 
weeks. Follow-up was only performed in the second case 
and a 40% reduction in the size of the lesion was evident. 
The patient was asymptomatic. 
The volume of ethanol used was determined according to 
the degree of diffusion within the lesion, with a change from 
a hypoechoic to a hyperechoic echo pattern. Due to the mild 
hepatitis experienced in the first case, the ethanol dose was 
decreased to 2 ml.
DISCUSSION
There is no consensus with regard to the appropriate vol-
ume, type of needle and clinical efficacy. To date, few pub-
lished cases have been reported (3-5). A literature review of 
GIST cases treated with EUS-guided ethanol-ablation was 
performed and a comparison with two reported cases is 
summarized in table 1.
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*Death before first control for reasons not related to the GIST or endoscopic therapy. CPN: Celiac plexus needle.
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